Viemed Healthcare US (VMD) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Viemed Healthcare reports a triumphant financial year for 2023, achieving record net revenues of $183 million and a net income increase of 65%, marking its seventh consecutive year of growth. The company also celebrated a significant surge in free cash flow and concluded the year with a strong balance sheet, despite taking on some long-term debt from a substantial acquisition. Looking ahead, Viemed anticipates revenues up to $51 million in the first quarter of 2024, independent of Medicare reimbursement rate adjustments.
For further insights into VMD stock, check out TipRanks’ Stock Analysis page.
